Brett Novey has served as PharmaCann’s CEO since August 2019 and has more than 20 years of professional experience across multiple disciplines including finance, operations, investor relations, business development, and investment management. Brett joined PharmaCann in 2016 and prior to becoming CEO, operated in the dual capacity as the Company’s CFO and COO. Before joining PharmaCann, Brett was the Global Head of Financial Planning & Analysis for KCG Holdings, Inc. (a NYSE listed corporation), where he was responsible for capital management, forecasting and budgeting, and assisting with KCG’s merger and acquisition activities, among other financial responsibilities. Prior to KCG, Brett worked for KPMG and Arthur Andersen in their respective restructuring practices. Brett holds a Bachelor’s degree in accounting and finance from Indiana University and a Master’s degree from Northwestern’s Kellogg School of Management.